(UroToday.com) In conjunction with the Scientific Congress held as part of the American Society of Clinical Oncology’s (ASCO) Annual Meeting in May 2020, an Educational Symposium was convened on August 8 to 10th. In a session entitled “Immune Checkpoint Blockade for Prostate Cancer: Niche Role or Next Breakthrough?”, Dr. Matt Rettig from the University of […]
(UroToday.com) In conjunction with the Scientific Congress held as part of the American Society of Clinical Oncology’s Annual Meeting in May 2020, an Educational Symposium was convened on August 8-10. In a session entitled “Sorting Through the Maze of Treatment Options for Metastatic Castration-Sensitive Prostate Cancer”, Dr. Carmel Jo Pezaro from Weston Park Hospital, Sheffield […]
(UroToday.com) In conjunction with the Scientific Congress held as part of the American Society of Clinical Oncology’s Annual Meeting in May 2020, an Educational Symposium was convened on August 8-10. In a session entitled “Sorting Through the Maze of Treatment Options for Metastatic Castration-Sensitive Prostate Cancer”, Dr. Carmel Jo Pezaro from Weston Park Hospital, Sheffield […]
(UroToday.com) In conjunction with the Scientific Congress held as part of the American Society of Clinical Oncology’s (ASCO) Annual Meeting in May 2020, an Educational Symposium was convened on August 8 to 10th. In a session entitled “Optimizing Cure for High-Risk Clinically Localized Prostate Cancer”, Dr. Felix Feng from the University of California San Francisco’s Helen […]
(UroToday.com) In conjunction with the Scientific Congress held as part of the American Society of Clinical Oncology’s (ASCO) Annual Meeting in May 2020, an Educational Symposium was convened on August 8 to 10th. In a session entitled “Optimizing Cure for High-Risk Clinically Localized Prostate Cancer”, Dr. Felix Feng from the University of California San Francisco’s Helen […]
(UroToday.com) Daniel Pryma, MD, discussed the current status of theranostics in 2020 as part of the recent advances in nuclear medicine theranostics for cancer session at the 2020 ASCO virtual education program. In the United States, there are varying regulatory constraints with different rules for compassionate use, reimbursement, and radiation safety. Additionally, theranostics in the United […]
(UroToday.com) Daniel Pryma, MD, discussed the current status of theranostics in 2020 as part of the recent advances in nuclear medicine theranostics for cancer session at the 2020 ASCO virtual education program. In the United States, there are varying regulatory constraints with different rules for compassionate use, reimbursement, and radiation safety. Additionally, theranostics in the United […]
(UroToday.com) The ASCO 2020 Virtual Education Program featured a session highlighting molecular enrichment strategies in genitourinary cancer, including Arlene Siefker-Radtke, MD, discussing new approaches to molecular enrichment for urothelial carcinoma. Dr. Siefker-Radtke notes that there are several components that make a good biomarker: It is easily reproducible: anyone can do it, it’s not open to interpretation […]
(UroToday.com) The ASCO 2020 Virtual Education Program featured a session highlighting molecular enrichment strategies in genitourinary cancer, including Arlene Siefker-Radtke, MD, discussing new approaches to molecular enrichment for urothelial carcinoma. Dr. Siefker-Radtke notes that there are several components that make a good biomarker: It is easily reproducible: anyone can do it, it’s not open to interpretation […]
(UroToday.com) The ASCO 2020 virtual education program featured a session on recent advances in nuclear medicine theranostics for cancer. As part of this session, Jonathan McConathy, MD, Ph.D., provided an introductory presentation to theranostics. The term ‘theranostic’ is derived from ‘therapeutic plus diagnostic’, which is a diagnostic test to stratify patients by likelihood to respond to […]
